Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Uncategorized

October 28, 2024 CD derivatives / Drug delivery / Pharma applications / Uncategorized

Long in vivo circulating nanomicelles formed by sharp-contrast Janus star polymers derived from β-cyclodextrin grafted with lipids and polyzwitterions

This work reports a rational design of a sharp-contrast Janus star polymer (SJSP) consisting of multiple arms of superhydrophobic lipid

Continue reading

October 18, 2024 Uncategorized

A concurrent drug delivery system: phytosomes. Improving the Cytotoxic Activity of Hinokitiol from Drug-Loaded Phytosomal Formulation Against Breast Cancer Cell Lines

Phytosomes represent an innovative approach to herbal medicine delivery that has garnered considerable attention in recent years. These novel formulations

Continue reading

October 14, 2024 Drug delivery / Pharma applications / Uncategorized

Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability

Tyrosine kinase inhibitors (TKIs) can inhibit edema and neovascularization, such as in age-related macular degeneration and diabetic retinopathy. However, their

Continue reading

October 11, 2024 Uncategorized

Special issue: “Applications of Biomaterials in Wearable Medical Devices and Bioelectronics”

Exploration of BioMat-X (EBMX) journal (https://www.explorationpub.com/Journals/ebmx) organizes a special issue “Applications of Biomaterials in Wearable Medical Devices and Bioelectronics”  https://www.explorationpub.com/Journals/ebmx/Special_Issues/259 To submit to

Continue reading

September 27, 2024 Uncategorized

Save the date: 8th European Cyclodextrin Conference, 9-12 September 2025

The 8th European Cyclodextrin Conference will be held on 9-12 September 2025 in Milan, Italy organized by the University of

Continue reading

September 3, 2024 Drug delivery / Pharma applications / Uncategorized

Rutin/Sulfobutylether-β-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection

Ocular pathologies present significant challenges to achieving effective therapeutic results due to various anatomical and physiological barriers. Natural products such

Continue reading

June 27, 2024 Uncategorized

Better understanding the limits of solvent-free complex formation, a study with progesterone.

The formation of inclusion complexes with cyclodextrin and derived materials is one of its main applications, and is also of

Continue reading

June 19, 2024 Drug delivery / Pharma applications / Uncategorized

Colonic Microbiota Responsive Polymer and Its Preparation Method and Use

An interesting patent application has been published disclosing CD-cellobiose or CD-lactose polymer for drug delivery targeted to the colon with

Continue reading

June 7, 2024 Events / Uncategorized

CycloLab recognized as “Research Center of Excellence” by the Hungarian Academy of Sciences

Seven Hungarian companies with CycloLab among them were awarded the qualification of “Research Center of Excellence”. The ceremony was held

Continue reading

April 30, 2024 CD as API / Pharma applications / Uncategorized

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis

This review provides a comprehensive overview of emerging nanomedicine-based strategies for targeted delivery of anti-atherosclerosis drugs, elucidating their distinct mechanisms

Continue reading

Posts pagination

«Previous Posts 1 … 7 8 9 10 11 … 17 Next Posts»

Recent Posts

  • Cyclodextrins Meet Spicy Food: HOOAGO
  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (817)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (234)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,221)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Cyclodextrins Meet Spicy Food: HOOAGO
  • Cyclodextrin for treating lymphedema
  • MANU-KAMU - Dog dental treats with cyclodextrin
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Lanosterol eye drops for cataract treatment
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • Cyclodextrins in veterinary medicine (Part 1)
  • α-CD as laxative for pets and CD as litter deodorant

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...